Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Health Services

WELL Health Technologies Corp. to acquire CRH Medical Corp

Announced Feb 8, 2021 · Closed Apr 28, 2021

Deal value$293MEV $356M
Premium83.0%To unaffected price
EV / Adj. EBITDA11.6x3.6x EV / Revenue
ConsiderationAll cash$4.00 per share

Transaction

Acquirer
WELL Health Technologies Corp. (WELL)
Target
CRH Medical Corp (CRH)
Buyer type
Strategic
Offer price per share
$4.00
Enterprise value
$356M
Status
Closed Apr 28, 2021

Deal protections

Break fee (target pays)
$10.0M · 3.4%
Reverse fee (buyer pays)
$10.0M · 3.4%
Go-shop
No-shop
Financing
Committed · HSBC, CIBC

Advisors

To the acquirer
Not disclosed
To the target
Citigroup, Canaccord Genuity

Sector context · Healthcare

Comparable deals
9 in the prior 24 months
Premium
83.0% vs. 52.8% sector median
EV / Adj. EBITDA
11.6x vs. 11.5x sector median
Break fee
3.4% vs. 2.8% sector median

Timeline

  1. AnnouncedFeb 8, 2021
  2. Proxy filedMar 5, 2021
  3. Definitive proxyMar 19, 2021
  4. Shareholder voteApr 16, 2021
  5. ClosedApr 23, 2021

Valuation · fairness opinions

Trading comparables$3.09$3.69
Trading comparables$3.41$4.11
Trading comparables$4.26$6.52
Precedent transactions$2.84$4.18
Discounted cash flow$2.82$3.71
Offer $4.00

Implied value per CRH Medical Corp share by analysis, from Canaccord Genuity.

Sources
  • 8-K (EX-99.1) · Feb 8, 2021
  • DEFA14A · Feb 8, 2021
  • 8-K (EX-99.1) · Apr 28, 2021

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.